The Journal of Allergy and Clinical Immunology
Volume 122, Issue 3 , Pages 529-536.e17 , September 2008

Genetic variation in immune signaling genes differentially expressed in asthmatic lung tissues

  • Karine Tremblay, MSc

      Affiliations

    • Hôpital Laval, Université Laval, Quebec, Canada
    • Département des sciences fondamentales, Université du Québec à Chicoutimi, Saguenay, Quebec City, Canada
    • ,
  • Denise Daley, PhD

      Affiliations

    • James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Annie Chamberland, MSc

      Affiliations

    • Département des sciences fondamentales, Université du Québec à Chicoutimi, Saguenay, Quebec City, Canada
    • ,
  • Mathieu Lemire, PhD

      Affiliations

    • Ontario Institute for Cancer Research, Toronto, Ontario, Canada
    • ,
  • Alexandre Montpetit, PhD

      Affiliations

    • McGill University and the Genome Quebec Innovation Centre, Montreal, Quebec, Canada
    • ,
  • Michel Laviolette, MD

      Affiliations

    • Hôpital Laval, Université Laval, Quebec, Canada
    • ,
  • Arthur W. Musk, MD

      Affiliations

    • Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Australia
    • ,
  • Alan L. James, MD

      Affiliations

    • Western Australian Sleep Disorders Research Institute, Sir Charles Gairdner Hospital, Nedlands, Australia
    • ,
  • Moira Chan-Yeung, PhD

      Affiliations

    • Occupational and Environmental Lung Disease Unit, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Allan Becker, MD

      Affiliations

    • Department of Pediatrics and Child Health, Manitoba Centre for Health Policy, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • Anita L. Kozyrskyj, BScPhm, PhD

      Affiliations

    • Department of Pediatrics and Child Health, Manitoba Centre for Health Policy, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
    • Faculty of Pharmacy and the Department of Community Health Sciences, Manitoba Centre for Health Policy, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • Andrew J. Sandford, PhD

      Affiliations

    • James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Thomas J. Hudson, MD

      Affiliations

    • Ontario Institute for Cancer Research, Toronto, Ontario, Canada
    • ,
  • Peter D. Paré, MD

      Affiliations

    • James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Catherine Laprise, PhD

      Affiliations

    • Département des sciences fondamentales, Université du Québec à Chicoutimi, Saguenay, Quebec City, Canada
    • University of Montreal Community Genomic Medicine Centre, Chicoutimi University Hospital, Saguenay, Quebec City, Canada
    • Corresponding Author InformationReprint requests: Catherine Laprise, PhD, Université du Québec à Chicoutimi, 555 boulevard de l'Université, Saguenay, Quebec, G7H 2B1, Canada.

Received 10 December 2007 ,Revised 14 April 2008 ,Accepted 23 May 2008.

References 

  1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720–1745
  2. Sandford A, Weir T, Pare P. The genetics of asthma. Am J Respir Crit Care Med. 1996;153:1749–1765
  3. Hoffjan S, Nicolae D, Ober C. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res. 2003;4:14
  4. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 2006;7:95–100
  5. Holloway JW, Koppelman GH. Identifying novel genes contributing to asthma pathogenesis. Curr Opin Allergy Clin Immunol. 2007;7:69–74
  6. Schmidt-Weber CB. Gene expression profiling in allergy and asthma. Chem Immunol Allergy. 2006;91:188–194
  7. Tremblay K, Lemire M, Provost V, Pastinen P, Renaud Y, Sandford AJ, et al. Association study between the CX3CR1 gene and asthma. Genes Immun. 2006;7:632–639
  8. Laprise C, Sladek R, Ponton A, Bernier MC, Hudson TJ, Laviolette M. Functional classes of bronchial mucosa genes that are differentially expressed in asthma. BMC Genomics. 2004;5:21–31
  9. Laitinen T, Daly MJ, Rioux JD, Kauppi P, Laprise C, Petays T, et al. A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet. 2001;28:87–91
  10. Heyer E, Tremblay M, Desjardins B. Seventeenth-century European origins of hereditary diseases in the Saguenay population (Quebec, Canada). Hum Biol. 1997;69:209–225
  11. Labuda M, Labuda D, Korab-Laskowska M, Cole DE, Zietkiewicz E, Weissenbach J, et al. Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am J Hum Genet. 1996;59:633–643
  12. Scriver CR. Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet. 2001;2:69–101
  13. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis. 1987;136:225–244
  14. Lemire M, Roslin NM, Laprise C, Hudson TJ, Morgan K. Transmission-ratio distortion and allele sharing in affected sib pairs: a new linkage statistic with reduced bias, with application to chromosome 6q25.3. Am J Hum Genet. 2004;75:571–586
  15. Chan-Yeung M, Manfreda J, Dimich-Ward H, Ferguson A, Watson W, Becker A. A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants. Arch Pediatr Adolesc Med. 2000;154:657–663
  16. Chan-Yeung M, Ferguson A, Watson W, Dimich-Ward H, Rousseau R, Lilley M, et al. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol. 2005;116:49–55
  17. Becker A, Watson W, Ferguson A, Dimich-Ward H, Chan-Yeung M. The Canadian asthma primary prevention study: outcomes at 2 years of age. J Allergy Clin Immunol. 2004;113:650–656
  18. Bégin P, Tremblay K, Daley D, Lemire M, Claveau S, Salesse C, et al. Association of urokinase-type plasminogen activator with asthma and atopy. Am J Respir Crit Care Med. 2007;175:1109–1116
  19. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med. 2005;171:109–114
  20. Palmer LJ, Knuiman MW, Divitini ML, Burton PR, James AL, Bartholomew HC, et al. Familial aggregation and heritability of adult lung function: results from the Busselton Health Study. Eur Respir J. 2001;17:696–702
  21. Moffatt MF, Schou C, Faux JA, Abecasis GR, James A, Musk AW, et al. Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample. Eur J Hum Genet. 2001;9:341–346
  22. Hill MR, James AL, Faux JA, Ryan G, Hopkin JM, le Souef P, et al. Fc epsilon RI-beta polymorphism and risk of atopy in a general population sample. BMJ. 1995;311:776–779
  23. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, et al. A genome-wide search for quantitative trait loci underlying asthma. Nature. 1996;383:247–250
  24. Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, Tiislar M, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet. 2005;37:1108–1112
  25. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004;74:106–120
  26. Lake SL, Blacker D, Laird NM. Family-based tests of association in the presence of linkage. Am J Hum Genet. 2000;67:1515–1525
  27. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol. 2004;26:61–69
  28. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol. 2000;19(suppl 1):S36–S42
  29. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol. 2003;25:115–121
  30. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity. 2005;95:221–227
  31. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004;74:765–769
  32. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
  33. Profita M, Vignola AM, Sala A, Mirabella A, Siena L, Pace E, et al. Interleukin-4 enhances 15-lipoxygenase activity and incorporation of 15(S)-HETE into cellular phospholipids in cultured pulmonary epithelial cells. Am J Respir Cell Mol Biol. 1999;20:61–68
  34. Profita M, Sala A, Riccobono L, Paterno A, Mirabella A, Bonanno A, et al. 15-Lipoxygenase expression and 15(S)-hydroxyeicoisatetraenoic acid release and reincorporation in induced sputum of asthmatic subjects. J Allergy Clin Immunol. 2000;105:711–716
  35. Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J, Serhan CN. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest. 1993;92:1572–1579
  36. Profita M, Sala A, Riccobono L, Pace E, Paterno A, Zarini S, et al. 15(S)-HETE modulates LTB(4) production and neutrophil chemotaxis in chronic bronchitis. Am J Physiol Cell Physiol. 2000;279:C1249–C1258
  37. Chu HW, Balzar S, Westcott JY, Trudeau JB, Sun Y, Conrad DJ, et al. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy. 2002;32:1558–1565
  38. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med. 2002;8:1018–1023
  39. Takata S, Matsubara M, Allen PG, Janmey PA, Serhan CN, Brady HR. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. J Clin Invest. 1994;93:499–508
  40. Reed CE. The natural history of asthma. J Allergy Clin Immunol. 2006;118:543–550
  41. Koh MS, Irving LB. The natural history of asthma from childhood to adulthood. Int J Clin Pract. 2007;61:1371–1374
  42. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4:45–61
  43. Heyer E, Tremblay M. Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am J Hum Genet. 1995;56:970–978
  44. Engert JC, Berube P, Mercier J, Dore C, Lepage P, Ge B, et al. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet. 2000;24:120–125
  45. Richter A, Rioux JD, Bouchard JP, Mercier J, Mathieu J, Ge B, et al. Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11. Am J Hum Genet. 1999;64:768–775
  46. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037–2048
  47. Simpson A, John SL, Jury F, Niven R, Woodcock A, Ollier WE, et al. Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am J Respir Crit Care Med. 2006;174:386–392

 Supported by a grant from AllerGen NCE, Inc (http://www.allergen-nce.ca/), the Canadian Institutes of Health Research, the Respiratory Health Network of the Fonds de la recherche en santé du Québec, and the Western Australia Healthway. K.T. is an AllerGen PhD trainee and is supported by the Fondation de l'Université Laval studentship. D.D. is supported by grants from the Canadian Institutes of Health Research (CIHR), the Institutes of Gender and Health, Genetics, Population and Public Health, a CIHR STIHR IMPACT fellowship, and the Lung Association of British Columbia. A.C. is supported by the Fondation de l'Université du Québec à Chicoutimi studentship. A.L.K. is the recipient of a CIHR New Investigator award. A.S. is the chairholder of the Canada Research Chair (www.chairs.gc.ca) on genetic susceptibility to inflammatory disease. P.D.P. is a Michael Smith Foundation and Jacob Churg Scholar. T.J.H. is recipient of an Investigator Award from the CIHR and a Clinician-scientist Award in Translational Research from the Burroughs Wellcome Fund. C.L. is the chairholder of the Canada Research Chair on genetic determinants in asthma and the director of the Genetics platform of the Respiratory Health Network (RHN) of the Fonds de la recherche en santé du Québec (FRSQ).

 Disclosure of potential conflict of interest: D. Daley has received grant support from Allergan, the Canadian Institutes of Health Research (CIHR), and the Michael Smith Foundation for Health Research. M. Laviolette has received grant support from the CIHR, Asthmatx, AstraZeneca, GlaxoSmithKline, and Merck-Frosst. A. L. James has received grant support from Merck, Sharpe, and Dohme. A. L. Kozyrskyj has received grant support from AllerGen NCE and the CIHR. A. J. Sandford has received grant support from the Canadian CF Foundation. T. J. Hudson has received grant support from the Allergen Network, the CIHR, and the Burroughs Wellcome Fund. P. D. Paré has received grant support from Merck. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01172-X

doi: 10.1016/j.jaci.2008.05.049

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 3 , Pages 529-536.e17 , September 2008

Article Tools

* Image Usage & Resolution